Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
76
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Verrica Pharmaceuticals Inc market cap is $49.56M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Verrica Pharmaceuticals Inc 52 week high is $9.82 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Verrica Pharmaceuticals Inc 52 week low is $2.77 as of November 20, 2026.
Verrica Pharmaceuticals Inc stock price today is $2.74.
Verrica Pharmaceuticals Inc stock price yesterday was $2.89.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Verrica Pharmaceuticals Inc's P/E ratio is -1.3.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Verrica Pharmaceuticals Inc P/B ratio is -8.2962.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Verrica Pharmaceuticals Inc 50-day moving average is $3.89.